Literature DB >> 21802455

Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia.

FuZhou Wang1, HaiBo Wu, ShiQin Xu, XiRong Guo, Jie Yang, XiaoFeng Shen.   

Abstract

In our previous study, peripheral inflammatory stimulation evoked production of macrophage migration inhibitory factor (MIF) in the spinal cord and found spinal microglia are the major source of MIF in this context. Given the contribution of the activated-microglia to the inflammatory neuropathy plus the role for upregulated COX 2 expression and PGE(2) production in the severity of clinical manifestations of these neuroinflammatory conditions, we herein tested the hypothesis that in vitro MIF stimulation to spinal microglia could result in an activation of COX 2-PGE(2) system by MIF-CD74 interaction. We found MIF played roles in evoking COX 2 mRNA and protein expression in a dose-dependent manner correspondingly in changes in PGE(2) level in the cultured rat microglia, but these changes could be inhibited by genetic deletion of CD74. Finally, MIF-induced COX 2-PGE(2) activation could be blocked by selective inhibitors of p44/p42 and p38 MAPKs. These data highlight MIF/CD74 interaction induces upregulation of COX 2 expression and PGE(2) secretion in primary rodent microglia, and further this effect is associated with downstream activation of p38 and p44/p42 signaling cascades, and favors the role of MIF as a novel pathway for microglia-associated neuroinflammation.
Copyright © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802455     DOI: 10.1016/j.neures.2011.07.1821

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  14 in total

1.  Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.

Authors:  Hanan Qasem; Laila Al-Ayadhi; Geir Bjørklund; Salvatore Chirumbolo; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2018-03-22       Impact factor: 3.584

2.  Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Mahtab Asadabadi; Mohammad-Reza Mohammadi; Ahmad Ghanizadeh; Amirhossein Modabbernia; Mandana Ashrafi; Elmira Hassanzadeh; Saeedeh Forghani; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2012-07-11       Impact factor: 4.530

3.  The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress.

Authors:  Andrea L Benedict; Elena V Knatko; Albena T Dinkova-Kostova
Journal:  Carcinogenesis       Date:  2012-09-15       Impact factor: 4.944

4.  MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.

Authors:  Kavitha Yaddanapudi; Beatriz E Rendon; Gwyneth Lamont; Eun Jung Kim; Numan Al Rayyan; Jamaal Richie; Sabrin Albeituni; Sabine Waigel; Ashley Wise; Robert A Mitchell
Journal:  Cancer Immunol Res       Date:  2015-11-24       Impact factor: 11.151

5.  Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.

Authors:  Jessica K Alexander; Gina M Cox; Jin-Bin Tian; Alicia M Zha; Ping Wei; Kristina A Kigerl; Mahesh K Reddy; Nilesh M Dagia; Theis Sielecki; Michael X Zhu; Abhay R Satoskar; Dana M McTigue; Caroline C Whitacre; Phillip G Popovich
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

6.  Neuroprotective effects of sulforaphane after contusive spinal cord injury.

Authors:  Andrea L Benedict; Andrea Mountney; Andres Hurtado; Kelley E Bryan; Ronald L Schnaar; Albena T Dinkova-Kostova; Paul Talalay
Journal:  J Neurotrauma       Date:  2012-09-20       Impact factor: 5.269

Review 7.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

Review 8.  Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part II).

Authors:  Fuzhou Wang; George B Stefano; Richard M Kream
Journal:  Med Sci Monit       Date:  2014-07-12

9.  Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.

Authors:  Omar Kassaar; Marta Pereira Morais; Suying Xu; Emily L Adam; Rosemary C Chamberlain; Bryony Jenkins; Tony D James; Paul T Francis; Stephen Ward; Robert J Williams; Jean van den Elsen
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

10.  Macrophage migration inhibitory factor mediates peripheral nerve injury-induced hypersensitivity by curbing dopaminergic descending inhibition.

Authors:  Xian Wang; Shaolei Ma; Haibo Wu; Xiaofeng Shen; Shiqin Xu; Xirong Guo; Maria L Bolick; Shizheng Wu; Fuzhou Wang
Journal:  Exp Mol Med       Date:  2018-02-16       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.